PL374312A1 - Śródbłonkowe komórki macierzyste, populacje, sposoby wyodrębniania oraz ich zastosowanie - Google Patents

Śródbłonkowe komórki macierzyste, populacje, sposoby wyodrębniania oraz ich zastosowanie

Info

Publication number
PL374312A1
PL374312A1 PL02374312A PL37431202A PL374312A1 PL 374312 A1 PL374312 A1 PL 374312A1 PL 02374312 A PL02374312 A PL 02374312A PL 37431202 A PL37431202 A PL 37431202A PL 374312 A1 PL374312 A1 PL 374312A1
Authority
PL
Poland
Prior art keywords
stem cells
methods
populations
isolation
endothelial stem
Prior art date
Application number
PL02374312A
Other languages
English (en)
Other versions
PL210872B1 (pl
Inventor
William C.III Fanslow
Anne-Marie C. Rousseau
Thomas O. Daniel
Original Assignee
Immunex Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corporation filed Critical Immunex Corporation
Publication of PL374312A1 publication Critical patent/PL374312A1/pl
Publication of PL210872B1 publication Critical patent/PL210872B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/069—Vascular Endothelial cells
    • C12N5/0691—Vascular smooth muscle cells; 3D culture thereof, e.g. models of blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/069—Vascular Endothelial cells
    • C12N5/0692—Stem cells; Progenitor cells; Precursor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
PL374312A 2001-12-21 2002-12-20 Zastosowanie przeciwciała specyficznego dla P1H12 do wytwarzania wzbogaconej populacji komórek macierzystych oraz wzbogacona populacja komórek macierzystych i populacja komórek potomnych PL210872B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34349801P 2001-12-21 2001-12-21

Publications (2)

Publication Number Publication Date
PL374312A1 true PL374312A1 (pl) 2005-10-03
PL210872B1 PL210872B1 (pl) 2012-03-30

Family

ID=23346359

Family Applications (1)

Application Number Title Priority Date Filing Date
PL374312A PL210872B1 (pl) 2001-12-21 2002-12-20 Zastosowanie przeciwciała specyficznego dla P1H12 do wytwarzania wzbogaconej populacji komórek macierzystych oraz wzbogacona populacja komórek macierzystych i populacja komórek potomnych

Country Status (11)

Country Link
US (1) US7833697B2 (pl)
EP (1) EP1465983B1 (pl)
JP (2) JP2005514062A (pl)
AT (1) ATE462782T1 (pl)
AU (1) AU2002360741B2 (pl)
CA (1) CA2469472C (pl)
DE (1) DE60235836D1 (pl)
ES (1) ES2341948T3 (pl)
MX (1) MXPA04006154A (pl)
PL (1) PL210872B1 (pl)
WO (1) WO2003060077A2 (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL210872B1 (pl) 2001-12-21 2012-03-30 Immunex Corp Zastosowanie przeciwciała specyficznego dla P1H12 do wytwarzania wzbogaconej populacji komórek macierzystych oraz wzbogacona populacja komórek macierzystych i populacja komórek potomnych
US7470538B2 (en) * 2002-12-05 2008-12-30 Case Western Reserve University Cell-based therapies for ischemia
CA2547899C (en) * 2002-12-05 2014-04-15 Case Western Reserve University Cell-based therapies for ischemia
US20070269412A1 (en) * 2003-12-02 2007-11-22 Celavie Biosciences, Llc Pluripotent cells
US20050232905A1 (en) * 2004-03-26 2005-10-20 Yeh Edward T Use of peripheral blood cells for cardiac regeneration
EP1745125A1 (en) * 2004-05-14 2007-01-24 Becton, Dickinson and Company Cell culture environments for the serum-free expansion of mesenchymal stem cells
JP5175092B2 (ja) 2004-06-01 2013-04-03 クワラタ トレーディング リミティド 幹細胞を用いるｉｎｖｉｔｒｏ技術
BRPI0607045A2 (pt) * 2005-01-31 2009-08-04 Cognate Therapeutics Inc células estromais adultas derivadas de adiposas exibindo caracterìsticas de células endoteliais
US9127302B2 (en) 2005-09-20 2015-09-08 Janssen Diagnostics, Llc System for the detection and enumeration of suspect target cells in a mixed cell population
US9134237B2 (en) 2005-09-20 2015-09-15 Janssen Diagnotics, LLC High sensitivity multiparameter method for rare event analysis in a biological sample
US20110076255A1 (en) 2005-11-07 2011-03-31 Pecora Andrew L Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency
US8637005B2 (en) 2005-11-07 2014-01-28 Amorcyte, Inc. Compositions and methods of vascular injury repair
PT1951864E (pt) * 2005-11-07 2014-08-27 Amorcyte Inc Composições e métodos de reparação de lesões vasculares
TW200734462A (en) 2006-03-08 2007-09-16 In Motion Invest Ltd Regulating stem cells
WO2008085229A2 (en) * 2006-11-15 2008-07-17 Arteriocyte Inc. Cell-based therapies for treating liver disease
WO2008107652A1 (en) 2007-03-02 2008-09-12 Smith & Nephew Plc Apparatus and method for filter cleaning by ultrasound, backwashing and filter movement during the filtration of biological samples
EP2343361A4 (en) * 2008-10-24 2013-10-09 Kuraray Co CELL CULTURE KIT, TEST PROCEDURE AND MANUFACTURING PROCESS FOR THE CELL CULTURE KIT
BRPI0920976A2 (pt) * 2008-12-03 2015-08-18 Amorcyte Inc Composições que melhoram a perfusão da area de infarto e metodos de restauração da lesão vascular.
US20100209399A1 (en) * 2009-02-13 2010-08-19 Celavie Biosciences, Llc Brain-derived stem cells for repair of musculoskeletal system in vertebrate subjects
CN103234993A (zh) * 2013-04-11 2013-08-07 哈尔滨体育学院 一种优秀冰雪运动员内皮祖细胞鉴定方法
CN103484423B (zh) * 2013-07-18 2015-06-24 浙江大学 一种分离培养家禽内皮祖细胞的方法
CN113444637B (zh) * 2021-01-28 2022-08-05 潍坊医学院 一种研究内皮祖细胞损伤修护的氢气培养实验系统及方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637481A (en) * 1993-02-01 1997-06-10 Bristol-Myers Squibb Company Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
US5980887A (en) * 1996-11-08 1999-11-09 St. Elizabeth's Medical Center Of Boston Methods for enhancing angiogenesis with endothelial progenitor cells
WO1999037751A1 (en) 1998-01-23 1999-07-29 Imclone Systems Incorporated Purified populations of stem cells
CA2351671A1 (en) * 1998-11-24 2000-06-08 Regents Of The University Of Minnesota Transgenic circulating endothelial cells
AU2001275339A1 (en) * 2000-06-05 2001-12-17 The Trustees Of Columbia University In The City Of New York Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury
PL210872B1 (pl) 2001-12-21 2012-03-30 Immunex Corp Zastosowanie przeciwciała specyficznego dla P1H12 do wytwarzania wzbogaconej populacji komórek macierzystych oraz wzbogacona populacja komórek macierzystych i populacja komórek potomnych

Also Published As

Publication number Publication date
AU2002360741A1 (en) 2003-07-30
US20030148512A1 (en) 2003-08-07
ES2341948T3 (es) 2010-06-30
WO2003060077A3 (en) 2003-12-31
CA2469472A1 (en) 2003-07-24
WO2003060077A2 (en) 2003-07-24
JP2008148702A (ja) 2008-07-03
MXPA04006154A (es) 2004-11-01
ATE462782T1 (de) 2010-04-15
JP2005514062A (ja) 2005-05-19
EP1465983A4 (en) 2006-01-11
DE60235836D1 (de) 2010-05-12
EP1465983A2 (en) 2004-10-13
US7833697B2 (en) 2010-11-16
PL210872B1 (pl) 2012-03-30
JP4447033B2 (ja) 2010-04-07
CA2469472C (en) 2013-11-26
AU2002360741B2 (en) 2008-07-17
EP1465983B1 (en) 2010-03-31

Similar Documents

Publication Publication Date Title
EP1465983A4 (en) ENDOTHELIAL STEM CELLS, POPULATIONS, METHODS OF ISOLATION AND USE THEREOF
ATE328067T1 (de) Isolierung von mesenchymalen stammzellen und deren verwendung
AU2002359522A8 (en) Compositions and methods of selective nucleic acid isolation
WO2002095055A3 (en) Compositions and methods for use in isolation of nucleic acid molecules
TNSN07235A1 (en) Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride
SG149061A1 (en) Definitive endoderm
AP2000001919A0 (en) Inhibitors of caspases.
WO2005003320A3 (en) Neuronal differentiation of stem cells
WO2004070013A3 (en) Use of islet 1 as a marker for isolating or generating stem cells
GB2392674A (en) Mesenchymal cells and osteoblasts from human embryonic stem cell
WO2003080801A3 (en) Adipose stromal stem cells for tissue and vascular modification
WO2006026570A3 (en) Use of stem cells to generate inner ear cells
MX2007005221A (es) Formas cristalinas de ascomicina y preparacion de ellas.
MXPA04004939A (es) 5,5??,6,6??,7,7??,8,8??-octahidro-2,2??-binaftoles 3-alquilados y 5,5??,6,6??,7,7??,8,8??-octahidro-2,2??-binaftoles 3,3??-dialquilados y procesos para su fabricacion.
MXPA05013553A (es) Pirrolodihidroisoquinolinas como inhibidores de pde10.
WO2005047494A3 (en) Haematopoietic stem cells suitable for transplantation, their preparation and pharmaceutical compositions comprising them
PL374080A1 (pl) Sposób wytwarzania fibrynogenu
MXPA03010158A (es) Sulfonamidas.
WO2006031926A3 (en) Methods for the isolation and expansion of cord blood derived t regulatory cells
MXPA04003755A (es) Endoprotesis vasculares.
DE69928820D1 (de) Akt zusammensetzungen zur steigerung des überlebens von kardiomyozyten
WO2002001951A3 (en) Optically pure(-) clethodim, compositions and methods for controlling plant growth comprising the same
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
WO2005074973A3 (en) Method of inducing or modulating immune response
PL1664307T3 (pl) Nowy, specyficzny dla bielma promotor roślinny dla roślin uprawnych